In the first nine months of 2022, The Joint Commission has issued sentinel events, released new guidance to improve patient safety, launched new certifications and more.
Genomic testing has been used for years on a case-by-case basis in clinical care, but is now increasingly seen as an important contributor to advancing population health.
Torrance (Calif.) Memorial Medical Center is the first to receive the Leading Laboratories designation from The Joint Commission and the American Society for Clinical Pathology.